OpenAlex
PricingAboutJobs
Log inGet started
Work

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

HTML

Year: 2006
Type: article
Source: Multiple Sclerosis Journal
DOI: 10.1191/135248506ms1318oa
Authors: C C Ford, K P Johnson, R P Lisak, H S Panitch, G Shifroni, J S Wolinsky, The Copaxone® Study Group
Institutions: Wayne State University, University of Vermont, Teva Pharmaceuticals (Israel), The University of Texas Health Science Center at Houston
Language: English

Topic: Multiple Sclerosis Research Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: glatiramer acetate, relapsing-remitting multiple sclerosis, long-term follow-up, relapse rate, Expanded Disability Status Scale, disability progression, ambulatory status, drug withdrawal, disease-modifying therapy
SDG: Good health and well-being

Open Access status: closed

Funders: Teva Pharmaceutical Industries, U.S. Food and Drug Administration
Award: G7960754321
OpenAlex ID: W2099210971
FWCI: 11.23
Cites: 20
Cited by: 148
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security